金达威(002626) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was CNY 743,170,048.30, a decrease of 5.99% compared to CNY 790,491,584.29 in the same period last year[12] - Net profit attributable to shareholders for Q1 2024 was CNY 70,793,791.49, down 18.58% from CNY 86,951,244.72 in the previous year[12] - Total operating revenue for Q1 2024 was ¥743,170,048.30, a decrease of 5.95% from ¥790,491,584.29 in the previous period[51] - The net profit for the first quarter was ¥70,882,477.49, a decrease of 15.3% compared to ¥83,634,871.69 in the previous year[52] - The company reported a total comprehensive income of ¥76,136,969.89, compared to ¥59,202,866.61 in the same period last year, indicating an increase of 28.6%[54] Cash Flow and Financial Position - The company's cash flow from operating activities decreased significantly by 98.32%, amounting to CNY 3,950,059.02 compared to CNY 235,416,458.25 in the same period last year[12] - The cash flow from operating activities showed a net increase of ¥3,950,059.02, significantly lower than the previous year's ¥235,416,458.25[57] - The cash and cash equivalents at the end of the period totaled ¥736,877,073.28, a decrease from ¥800,705,490.96 at the end of the previous year[60] - The company incurred a total of ¥694,317,278.84 in cash outflows from operating activities, compared to ¥538,255,431.18 in the previous year, representing an increase of 29%[57] - The net cash flow from financing activities was ¥155,799,164.08, an increase from ¥96,359,432.55 in the previous year[60] Assets and Liabilities - The total assets as of March 31, 2024, were CNY 5,561,221,522.45, reflecting a 3.88% increase from CNY 5,353,392,042.82 at the end of the previous year[12] - Total assets as of the reporting date were ¥5,561,221,522.45, an increase from ¥5,353,392,042.82 in the previous period[46] - Total liabilities increased to ¥1,548,593,807.05 from ¥1,416,901,298.61, representing a rise of 9.28%[45] - Current liabilities totaled ¥833,906,555.04, an increase from ¥664,032,640.34, marking a rise of 25.5%[45] - The company's total equity increased to ¥4,012,627,715.40 from ¥3,936,490,744.21, reflecting a growth of 1.93%[46] Investments and Expenses - The company’s investment income from joint ventures and associates decreased by 60.26% to CNY 869,250.55 from CNY 2,187,471.66[5] - Research and development expenses increased to ¥16,083,859.74, up 10.63% from ¥14,539,086.42 in the previous period[51] - The company reported a significant reduction in financial expenses by 84.19%, totaling CNY 1,853,819.67 compared to CNY 11,724,795.12 in the previous year[5] - The company reported a decrease in financial expenses to ¥1,853,819.67 from ¥11,724,795.12, a reduction of approximately 84.16%[51] - The total impairment losses for assets were ¥1,470,118.89, a decrease from ¥2,411,251.70 in the previous year, indicating a reduction of 39%[52] Operational Incidents and Acquisitions - The company reported a significant incident at its facility, resulting in 3 fatalities and 3 injuries, which may impact operational capacity[30] - The company announced the acquisition of 100% equity in Activ Nutritional, LLC from Viactiv Nutritionals, Inc. for $1.7 million, pending regulatory approvals[33] - The company holds a 96.11% stake in its U.S. subsidiary, Doctor's Best Inc., which is involved in the acquisition mentioned above[33] - The company has entered a recovery phase following the incident at its facility, indicating a focus on resuming normal operations[30] Shareholder Information - The company confirmed that there are no non-recurring gains classified as recurring gains in its financial statements[25] - The company has not identified any related party transactions among its top shareholders[27] - The total number of shares held by the top 10 shareholders includes significant stakes from Xiamen Jindawei Investment Co., Ltd. and Zhongmu Industrial Co., Ltd.[27]